BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34711331)

  • 1. Advancing sensing technology with CRISPR: From the detection of nucleic acids to a broad range of analytes - A review.
    Xie S; Ji Z; Suo T; Li B; Zhang X
    Anal Chim Acta; 2021 Nov; 1185():338848. PubMed ID: 34711331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis.
    Chen K; Shen Z; Wang G; Gu W; Zhao S; Lin Z; Liu W; Cai Y; Mushtaq G; Jia J; Wan CC; Yan T
    Front Bioeng Biotechnol; 2022; 10():986233. PubMed ID: 36185462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel non-nucleic acid targets detection strategies based on CRISPR/Cas toolboxes: A review.
    Cheng X; Li Y; Kou J; Liao D; Zhang W; Yin L; Man S; Ma L
    Biosens Bioelectron; 2022 Nov; 215():114559. PubMed ID: 35917610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in CRISPR sensing and detection technology].
    Wang J; Zhao P; Qin M; Zhao Y; Liu C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):367-377. PubMed ID: 38369827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
    Wei C; Lei X; Yu S
    ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress on the CRISPR/Cas system in optical biosensors.
    Li B; Zhai G; Dong Y; Wang L; Ma P
    Anal Methods; 2024 Feb; 16(6):798-816. PubMed ID: 38259224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in CRISPR/Cas-Based Biosensors for Protein Detection.
    Wang J; Yang X; Wang X; Wang W
    Bioengineering (Basel); 2022 Sep; 9(10):. PubMed ID: 36290480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights for Biosensing: Lessons from Microbial Defense Systems.
    Wan Y; Zong C; Li X; Wang A; Li Y; Yang T; Bao Q; Dubow M; Yang M; Rodrigo LA; Mao C
    Chem Rev; 2022 May; 122(9):8126-8180. PubMed ID: 35234463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas12-based electrochemical biosensors for clinical diagnostic and food monitoring.
    Yudin Kharismasari C; Irkham ; Zein MIHL; Hardianto A; Nur Zakiyyah S; Umar Ibrahim A; Ozsoz M; Wahyuni Hartati Y
    Bioelectrochemistry; 2024 Feb; 155():108600. PubMed ID: 37956622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.
    Roueinfar M; Templeton HN; Sheng JA; Hong KL
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical CRISPR/Cas12a-based technology: A novel horizon for biosensing in nucleic acid detection.
    Lei X; Cao S; Liu T; Wu Y; Yu S
    Talanta; 2024 May; 271():125663. PubMed ID: 38232570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodologies in visualizing the activation of CRISPR/Cas: The last mile in developing CRISPR-Based diagnostics and biosensing - A review.
    Sohail M; Xie S; Zhang X; Li B
    Anal Chim Acta; 2022 May; 1205():339541. PubMed ID: 35414381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas12-based nucleic acids detection systems.
    Leung RK; Cheng QX; Wu ZL; Khan G; Liu Y; Xia HY; Wang J
    Methods; 2022 Jul; 203():276-281. PubMed ID: 33662563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versatile CRISPR-Cas12a-Based Biosensing Platform Modulated with Programmable Entropy-Driven Dynamic DNA Networks.
    Wang C; Han C; Du X; Guo W
    Anal Chem; 2021 Sep; 93(38):12881-12888. PubMed ID: 34521192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.